References
Cunliffe, W.J., Sudhakaran Menon, I. The association between cutaneous vasculitis and decreased blood fibrinolytic activity. Br J Derm 1971, 84, 99–105.
Jordan, J.M., Bates Allen, N., Pizzo, S.V. Defective release of tissue plasminogen activator in systemic and cutaneous vasculitis. Am J Med 1987, 82, 397–400.
Moussoni, L., Pintucci, G., Romano, G., De Benedetti, F., Massa, M., Martini, A. Decreased fibrinolytic activity in juvenile chronic arthritis. Ann Rheum Dis 1990, 49, 973–975.
Nusinow, S.R., Federici, A.B., Zimmerman, T.S., Curd, J.G. Increased von Willebrand factor antigen in the plasma of patients with vasculitis. Arthritis Rheum 1984, 27, 1405–1410.
Woolf, A.D., Wakerly, G., Wallington, T.B., Scott, D.G.I., Dieppe, P.A. Factor VIII related antigen in the assessment of vasculitis. Ann Rheum Dis 1987, 46, 441–447.
Federici, A.B., Fox, R.I., Espinoza, L.R., Zimmerman, T.S. Elevation of von Willebrand factor is independent of erythrocyte sedimentation rate and persists after glucocorticoid treatment in giant cell arteritis. Arthritis Rheum 1984, 27, 1046–1049.
Blann, A.D., Wainwright, A.C., Emery, P. Damage to the endothelium in Sjögren's syndrome: lack of correlation with antinuclear antibody titre and presence of antibodies to SSA or SSB. Ann Rheum Dis 1992, 51, 389–390.
Nylander-Lundqvist, E., Bäck, O., Nilsson, T.K., Rantapää Dahlqvist, S. Prevalence of anti-endothelial cell antibodies in patients with autoimmune diseases. Clin Rheumatol 1992, 11, 248–253.
Harley, J.B., Alexander, E.L., Bias, W.B. et al. Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome. Arthritis Rheum 1986, 29, 196–206.
Alexander, E.L., Arnett, F.C., Provost, T.T., Stevens, M.B., Sjögren's syndrome: Association of anti-Ro (SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med 1983, 98, 155–159.
Homma, M., Tojo, T., Akizuki, M., Yamagata, H. Criteria for Sjögren's syndrome in Japan. Scand J Rheumatol 1986, suppl 61, 26–27.
Chmielewska, J., Wiman, B. Determination of tissue plasminogen activator and its fast inhibitor from plasma. Clin Chem 1986, 32, 482–485.
Cejka, J. Enzyme immunoassay for factor VIII-related antigen. Clin. Chem. 1982, 28, 1356–1358.
Nilsson, T.K., Sondell, K., Norberg, B.O., Bäck, O. Plasma levels of endothelial-derived haemostatic factors in autoimmune thrombocytopenia and haemolytic anaemia. J Intern Med 1990, 228, 249–252.
Pottinger, B.E., Read, R.C., Paleolog, E.M., Higgins, P.G., Pearson, J.D. Von Willebrand factor is an acute phase reactant in man. Thrombosis Research 1989, 53, 387–394.
Danielsson, Å., Nilsson, T.K., Uddenfeldt, P. Alternations in C1 inhibitor and clotting factor concentrations in primary biliary cirrhosis and other chronic liver diseases. Scand J Gastroenterol 1990, 25, 149–154.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rantapää-Dahlqvist, S., Nilsson, T.K. Endothelial cell derived factors in relation to antibodies to SSA or SSB and to endothelial cells in Sjögren's syndrome. Clin Rheumatol 13, 320–322 (1994). https://doi.org/10.1007/BF02249038
Issue Date:
DOI: https://doi.org/10.1007/BF02249038